America pays less, on average, than any other major country for our generic drugs. But selling essential drugs at such low prices comes with hidden costs — from quality problems to frequent shortages.
This is the second episode of Race to the Bottom, a three-part series by Tradeoffs on the problems plaguing the generic drugs we all rely on — and how we could fix them.
Guests:
Christine Baeder, MBA, President, Apotex USA
Laura Bray, MBA, Founder, Angels for Change
Craig Burton, Senior Vice President of Policy and Strategic Alliances, Association for Accessible Medicines
Iilun Murphy, MD, Director of the Office of Generic Drugs, FDA
Leslie Walker, Senior Reporter/Producer, Tradeoffs
Marta Wosińska, PhD, Senior Fellow, Brookings Institution
Learn more and read a full transcript on our website.
Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.
Support this type of journalism today, with a gift.
","author_name":"Tradeoffs"}